Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antitrust Concerns Don’t Cloud Merck-Schering Deal

Executive Summary

Merck and Schering Plough may not have to shed many compounds to get the Federal Trade Commission to approve their merger as there appears to be very little product overlap

You may also be interested in...



Schering Helps Merck Where It’s Needed Most: The Pipeline

Bulking up the pipeline is a frequent motive for a pharmaceutical merger - but somewhat unusual for Merck, a company that has long prided itself on the strength of its R&D activity

Schering Helps Merck Where It’s Needed Most: The Pipeline

Bulking up the pipeline is a frequent motive for a pharmaceutical merger - but somewhat unusual for Merck, a company that has long prided itself on the strength of its R&D activity

Antitrust Enforcement Under Obama: Pfizer-Wyeth Offers An Early Test

President Obama pledged to reinvigorate antitrust enforcement during his campaign for the Oval Office. Pfizer's proposed acquisition of Wyeth gives the administration an early opportunity to test that promise

Topics

UsernamePublicRestriction

Register

LL029263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel